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ABSTRACT 
Objective: Methylphenidate [MPH] is one of the drugs of choice for children with Attention Deficit Hyperactivity Disorder [ADHD] since many 
decades with good effect. Consumption of this drug by normal children and adolescents to boost their cognition skills is of concern. MPH induced 
cognitive enhancement involves brain dopamine and norepinephrine levels in areas concerned with cognition especially hippocampus. Altered 
expression of these neurotransmitters can affect neuronal population of hippocampus which may have the significant effect in later part of the life. 
Hence we evaluate the effect of MPH on cognition and histopathological changes in the hippocampus and dentate gyrus. 
Methods: Two month old male wistar rats were given either 2 or 5 mg/kg dose of MPH for 10 successive days and another set of rats served as 
control. The rats were tested for learning and memory activities followed by histopathological studies in hippocampus and dentate gyrus using Nissl 
staining. 
Results: MPH at both the doses has enhanced learning abilities as well as retention of memory. The histopathological studies did not show any 
significant effect on dentate gyrus as well as hippocampus. 
Conclusion: Though MPH is known to provide sound results in ADHD, from the present study it is clear that MPH treatment in normal rats also 
temporarily enhance the cognitive skills especially declarative memory. However, its effect on long term memory is to be investigated. MPH 
treatment has not affected the neuronal population hence possible cytotoxic effects on neurons can be ruled out from the present study. 
Keywords: Attention deficit hyper activity disorder, Cognitive function, Learning, Memory, Methylphenidate, Hippocampus. 
 
INTRODUCTION 
MPH is generally used to treat ADHD in children. MPH is proved to 
be effective in reducing hyperactivity and improving attentiveness 
[1] in children with ADHD. Of late there is a tendency to use MPH by 
people who are seeking to boost their cognition [2]. In United States 
of America 7% of the students are using nootrophics and this 
percentage rises to 25% at some establishments [3]. MPH is known 
to be an inhibitor of dopamine and nor-epinephrine transporter [4]. 
Inadequate research was performed in normal children in which 
improvement in attention was observed [5], recall [6], and spatial 
working memory [7]. However, the exact effect of MPH depends on 
many factors. While research in children with ADHD is limited, 
research in healthy animals would be more useful.  
Numbers of studies using oral administration of MPH in rats at the 
doses relevant to humans are targeted. Studies have focused mainly 
on nucleus accumbens (NAc), prefrontal cortex (PFC), and 
hippocampal regions of the rats, which are mainly concerned with 
cognition. These studies have revealed an increased dopamine [DA] 
in the NAc and in the PFC [8] and increased nor-epinephrine [NE] 
levels in the hippocampus [9]. Both NE and DA have a critical 
influence on PFC and hippocampus dependent cognitive functioning 
[10]. Though these studies throw light on MPH-induced cognitive 
enhancement involves the prefrontal cortex NE and DA system, 
whether these changes involve morphological changes in the regions 
of the brain involved in cognition is not known. Manipulation of 
neurotransmitters like NE and DA can cause adverse effect on 
neuronal population of the hippocampus [11]. Dentate gyrus is an 
area of active neuronal population which in turn required for 
hippocampal structural and functional plasticity [12]. Temporary 
enhancement of cognition though sounds good, it is necessary to 
evaluate MPH administration effect on neuronal population. Adverse 
effect if any on neuronal population has to be investigated. Hence in 
the present study we evaluate the MPH treatment effect in young 
rats on cognition and neuronal morphology of the hippocampus and 
dentate gyrus. 
MATERIALS AND METHODS 
Animals 
In-house bred two months old male albino Wistar rats were used in 
the present study. Rats were fed with water and food ad libitum. The 
rats were maintained under controlled conditions of light-dark cycle 
(12:12), temperature (22±3 °C), humidity (approximately 50±10%) 
and pathogen free environment. Polypropylene cage with paddy 
husk as bedding material was used for housing the rats. Institution 
animal ethics committee approval was obtained before commencing 
the experiment [letter dated 28/02/2014]. 
Animal groups 
The experiment consisted of following animal groups (n=6).  
Group 1: Control rats  
Group 2: Rats received 2 mg/kg MPH twice daily for 10 consecutive 
days  
Group 3: Rats received 5 mg/kg MPH twice daily for 10 consecutive 
days  
MPH was administered intraperitoneally. The rats were tested for 
learning and memory activities as well as histomorphological 
studies immediately after cessation of MPH treatment.  
Condition avoidance test (Active avoidance/Shuttle box test)  
This test evaluates the learning and memory abilities of the rats. The 
shuttle box consisted of a closed wooden box with shutters in front. 
The floor area was made up of grids, which were separated into two 
parts by a median grid. Each part was connected to separate electric 
circuits and a buzzer was fixed inside the box. Individual rats were 
allowed to explore the test box for 5 min. After 10 seconds, a 
discriminative stimulus was given through a buzzer. During that 
period, the rat could avoid the shock by crossing to the other 
compartment. If the rat failed to respond during the discriminative 
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stimulus period, it received a shock of 2.5mA for a maximum period 
of 10 seconds, during which, it could escape by crossing to the other 
side. The contingency for avoiding the shock was a single crossing 
over the median grid from one side of the shuttle box to the other. 
The test consisted of 30 trials daily for 5 consecutive days. The 
number of shock avoidances increases from day 1 to 5 of the test 
under normal circumstances. The average shock avoidance numbers 
on all 5 d were termed as the mean score during 5 d of testing. Any 
decrease in this score was an indication of learning impairment. 
Each rat was retested one week after the last trial to assess retention 
of memory. A comparison of rat’s performance with its previous 
performance gives the assessment of memory and is presented as 
the retention score (RTS), which is calculated as in [11].  
 
RTS =
Mean of retest score X Mean scoring during 5 d of testing
Mean score during day 5 of the testing
 
Any decrease in the retest score and retention score was an 
indication of memory impairment. Each rat was trained for 4 d 
before starting the test.  
Neuronal assay of the hippocampus& dentate gyrus (cresyl 
violet staining)  
Perfusion: Rats were deeply anaesthetized with ether and secured 
on a dissection board, and its chest cavity was opened to expose the 
heart. About 15 ml of 0.9% saline was perfused through the left 
ventricle at the rate of 1 ml/min. This was followed by perfusion of 
10% formalin at the same flow rate. The animal was decapitated and 
the brain was removed and kept in 10% formalin for 48h (post 
fixation). Paraffin blocks were made in an embedding bath. Coronal 
sections of 5μm thickness were cut in the dorsal hippocampus using 
a rotary microtome (Jung Biocutt 2035, Leica, Germany). Ten 
sections from each animal were mounted serially on air dried 
gelatinized slides.  
Staining 
The sections were stained with cresyl violet stain. One hundred 
milligrams of cresyl violets was dissolved in 100 ml of distilled 
water. To this 0.5 ml of 10% acetic acid was added to give a pH of 
3.5-3.8. The stain was filtered before use [11].  
Scoring 
The slides are screened using a Nikon trinocular microscope 
(H600L) under 40X magnification. In each hippocampal section, 
cornua amonis (CA2, CA3, CA4; 250μm length) of hippocampus and 
dentate gyrus (200μm2
Statistical analysis 
 length) were selected using imaging 
software NIS Elements Br version 4.30and the numbers of viable 
neurons were counted. Slides from different groups of rats were 
decoded to avoid manual bias while counting the cells. The cell 
counts were expressed as the number of cells per unit length of the 
cell field (cells/250μm length).  
The data were expressed as mean±SD. The significance of differences 
among the groups was assessed using one-way analysis of Variance 
(ANOVA) test followed by Bonferroni’s multiple comparison post hoc 
test. P values<0.05 were considered as significant.  
RESULTS 
Condition avoidance test 
MPH at both doses has significantly (p<0.001) increased mean of 5 d 
score compared to control rats. This is an indication of increased 
learning ability. There was also a moderately significant (p<0.05) 
difference between the two doses of MPH treatment, where 5 mg/kg 
dose found to be more affective. The retest score was also increased 
significantly (p<0.001) in both the doses of MPH treatment 
compared to control. The memory retention score was significantly 
increased in both the doses of MPH treatment compared to control. 
At 2 mg/kg dose the significant was p<0.01 and at 5 mg/kg dose was 
p<0.001. There was no statistically significant difference between 
two doses of MPH treatment as far as memory retention score was 
concerned (fig. 1). 
 
Fig. 1: Observation of condition avoidance test by control and 
MPH treated rats. Values are expressed as mean. Error bar 
indicates±SD. Comparison between control Vs MPH treatment, 
** =P<0.01, *** =p<0.001, Comparison between MPH2 mg/Kg Vs 
MPH 5 mg/kg, # = p<0.05 
 
Neuronal assay of dentate gyrus and hippocampus:  
The quantitative estimation of neurons in dentate gyrus region of 
the rat did not show any statistically significant (p>0.05) difference 
between control and MPH treated groups. However there was a 
significant (p<0.001) difference in number of neurons between 2 
and 5 mg/kg dose of MPH treated rats. The quantification of neurons 
in CA4, CA3 and CA2 regions of the rat hippocampus did not show 
any statistically significant (p>0.05) difference between control and 
MPH treated groups (fig. 2, 3 and 4). 
 
 
Fig. 2: Observation of neuronal assay in hippocampus and dentate 
gyrus. In hippocampus the numbers of neurons were counted in 
250 µm length area and in dentate gyrus 200 µm2
 
 area. Values are 
expressed as mean. Error bar indicates±SD. Comparison between 
MPH2 mg/Kg Vs MPH 5 mg/kg, *** =p<0.001 
DISCUSSION 
The results of the present study clearly demonstrate that MPH 
treatment in normal rats improves their learning ability and also 
retention of learnt things in the form of memory with an immediate 
effect. Though MPH is prescribed in clinically confirmed conditions 
of ADHD in children as well as in adults, of late it has been misused 
as stimulant to enhance the performance in examinations by 
students [13]. Earlier studies have proved that MPH treatment in 
children as well as adults with ADHD, to improve the working 
memory [14-16]. In the present study the condition avoidance task 
not only tests the learning ability of the rats but also memory 
retention. Rats were tested whether they can escape from the foot 
shocks from their past memory, which can be considered as 
declarative memory. Declarative memory is the ability to recall the 
facts, ideas or plans from past memory. As far as MPH effect on such 
memory function is less reported. These kinds of declarative memory 
are very much required in daily life and in social interaction [17]. 
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There are also different reports with respect to declarative memory. 
A study reports [6] considerable memory enhancement in healthy 
volunteers who received MPH, but another study [18] did not find 
any significant effect of MPH on memory function in healthy 
volunteers. MPH treatment in patients with ADHD [19] has benefited 
in improving the memory. In the present study normal rats showed 
a significant improvement in learning and memory abilities and our 
results are in consistent with Riordan et al. Since MPH can enhance 
the cognitive skills in normal condition, its misuse among the 
student community is of serious concern. Its long-term effect like 
substance abuse in later life is also another concern.  
There is also an apprehension that usage of MPH in normal children 
can boost short term memory at the cost of long term memory [20]. 
Hence further study is warranted to evaluate whether MPH would 
adversely affect long term memory. 
 
 





Fig. 4: Photomicrographs of CA3 region of the rat hippocampus under 40X magnification, stained with cresyl violet. Scale bar indicates 
50πm length area 
 
The mechanism of ADHD is due to under performance of dopamine 
and norepinephrine especially in the hippocampus and prefrontal 
cortex of the brain. These areas are concerned with higher functions 
like motivation, inhibition, memory, planning, reasoning and 
foresight [21]. MPH is primarily acts by inhibiting transport of 
dopamine and also norepinephrine, which in turn leads to elevation 
of its concentration in synaptic cleft. It would be interesting to 
evaluate these effects on neurons of the hippocampus after MPH 
treatment. In the present study, the neuronal assay of dentate gyrus 
and hippocampus showed that MPH treatment has not affected the 
number of normal neurons. This implies that, despite the efficiency 
of MPH in inducing changes in the dopaminergic system and thereby 
enhancing cognition, it has not caused either loss of neurons or 
promoting neurogenesis especially in dentate gyrus where 
neurogenesis continues even during adulthood.  
The rationale of evaluating the neuronal number was because there 
was also a report claiming loss of dopaminergic neurons after MPH 
treatment in mice [22]. Though our study did not evaluate the 
dopaminergic neurons in specific, but considering the fact that 
hippocampus present a high number of dopaminergic neuronal 
population, actual loss if any would fairly provide an indication. It 
would be interesting to see whether it promotes the survival of 
healthy neurons, but this would require immunohistochemistry 
studies. In the present study there was a significant decline in 
neuronal number in MPH-5 mg/kg treated rats compared to 2 
mg/kg dose, but their number did not differ from the base line. Few 
of the in vitro studies have claimed that MPH enhances the neuronal 
stem cell proliferation [23].  
MPH is prescribed in ADHD conditions, but in the present study we 
tested its effect on normal rats, since there is an increased tendency 
to use MPH among normal children, adolescents and even adults as a 
performance enhancer. The present study did not focus on 
hyperactivity, which is a common feature of ADHD, because we 
aimed to see its effect in normal rats.  
CONCLUSION 
MPH treatment certainly enhances learning abilities and memory 
retention in normal rats. MPH induced cognitive enhancement does 
not affect the neuronal population of dentate gyrus and 
hippocampus. MPH is used mainly in children with ADHD, which is 
known to reverse the symptoms of ADHD and promote the learning 
skills in children and in adolescents.  
However, from the present study it is clear that MPH treatment in 
normal rats also temporarily enhance the cognitive skills especially 
declarative memory. However, its effect on long term memory is to be 
investigated. MPH treatment has not affected the neuronal population in 
the present study. Use of MPH to enhance the academic performances by 
students and its long term effects needs to be discussed further.  
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